Conference Call With avVaa CEO, Jack Farley (OTC:AVVH)
At this time we would like to announce that StocksHaven Investments and avVaa World Health Care Products Inc. (OTC:AVVH) have reached an agreement with regards to a six month investor relations contract. This contract includes three articles, two conference calls and ongoing company updates through our newsletter distribution services. Furthermore, on 9/23/09, Founder and Lead Investment Analyst, Michael Vlaicu has established a conference call with avVaa’s CEO, President and Director, Jack Farley. The exact time of the call has yet to be determined.
Moreover, StocksHaven Investments announces that they have opened up the option of submitting questions to be reviewed, which could possibly lead to being asked during the interview process. Potentially acceptable topics include: future revenue projections, ongoing business operations, financial status, new products currently in the research and development stage, past issues which discouraged potential investors ( ex. online credit card payment problems ). Please use the contact us section of the website, and include the title “AVVH Interview Questions” during any submissions.
The conference call will be available on StocksHaven.com shortly after it has concluded.
Disclosure: Position in AVVH
To feature your publicly traded company in StocksHaven.com Alerts or as a fully profiled company, email us at firstname.lastname@example.org or visit http://www.stockshaven.com/ir_contract/ for more info
About StocksHaven Investments
StocksHaven Investments can be found at StocksHaven.com. It is a company offering a news portal covering the world financial news and equities sector. It features its own blog, free level 2 quotes, two way linking capability, mass e-mail distribution alerts, stock research reports, conference calls, news feeds, mailing list, videos, press release capability, stock commentaries, company reviews and other unique content including expert stock analysis from Michael Vlaicu. The company also offers Investor Relations contracting services.
For more financial and investment news, visit www.StocksHaven.com
Certain sections of this report contain forward-looking statements that are based on our reporters’ expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements, which include but are not limited to projections of revenues, earnings, segment performance, cash flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors including but not limited to the status or outcome of legal and/or regulatory proceedings.
All forward-looking statements speak only as of the date of this report or, in the case of any document incorporated by reference, the date of that document. All subsequent written and oral forward-looking statements attributable to the company or any person acting on the company’s behalf are qualified by the cautionary statements in this section. StocksHaven.Com does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this report.
- Contact Information
- Michael Vlaicu
- Founder and Lead Investment Analyst
- StocksHaven Investments
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.